@merlintrader.bsky.social📅 CATALYST REMINDER | $TGTX
October 21–23, 2026 — Clinical Data Presentations
Oct 21: BRIUMVI long-term/real-world data. Oct 22: ENHANCE dosing data. Oct 23: Phase 1 azer-cel in progressive MS.
🔗 Full details: www.merlintrader.com/tg-therapeut...
#TGTX #Biotech #MSToronto2026
@vindicomeded.bsky.socialComing up Wednesday at #MSToronto2026!
Join us for Unifying Evolving Paradigms in MS: From Early Diagnosis to Next-Gen Treatment and Monitoring at the Metro Toronto Convention Centre, South Building.
Sign up for reminders >> https://events.vindicocme.com/15kYU86/5a2BUm3X5K9
@neurologyadvisor.bsky.socialCompared with air pollution, high #BMI accounted for a significantly greater proportion of pediatric-onset #MultipleSclerosis prevalence, highlighting childhood obesity as a critical modifiable risk factor.
@neurologyadvisor.bsky.social#MSToronto2026 - Patients with #NeuromyelitisOptica spectrum disorder who initiated disease-modifying therapy within 90 days of a relapse exhibited a greater probability of confirmed disability improvement.
@neurologyadvisor.bsky.socialExplore the key research topics and clinical advances that will shape discussions at #MSToronto2026, the joint ACTRIMS/ECTRIMS meeting on MS and related disorders.
@vindicomeded.bsky.socialWhat could Bruton tyrosine kinase inhibitors mean for the future of MS care?
Explore their emerging role in the MS treatment landscape during this interactive CE symposium at #MSToronto2026 on Wednesday, October 21.
Register now >> https://events.vindicocme.com/15kYU86/5a2BUm3X5K9
@newsen.bsky.socialImmunic Announces Promising Vidofludimus Calcium Data at MSToronto2026 #United_States #New_York #Immunic #Vidofludimus_Calcium #MSToronto2026
@vindicomeded.bsky.socialHow are you approaching complex MS cases? At #MSToronto2026, expert faculty will work through real-world patient scenarios and share practical strategies for navigating today’s MS treatment landscape.
Register now >> https://events.vindicocme.com/15kYU86/5a2BUm3X5K9
@vindicomeded.bsky.socialJoin Drs. Patricia K. Coyle and Mark S. Freedman at #MSToronto2026 as they explore the emerging role of Bruton tyrosine kinase inhibitors in MS treatment.
Register now >> https://events.vindicocme.com/15kYU86/5a2BUm3X5K9
@vindicomeded.bsky.socialPut clinical decision-making into action at #MSToronto2026.
During our Rapid-Fire Roundtable, expert faculty will tackle key questions and practical challenges in MS care.
Save your seat >> https://events.vindicocme.com/15kYU86/5a2BUm3X5K9